Taiwan FDA registration d4d0a851bb52dbbe277362c8559fc7ac
Wudingliu glucose quality control solution (unsterilized)
TW: 五鼎六葡萄糖品管液(未滅菌)
Taiwan·Risk Class 1·APEX BIOTECHNOLOGY CORPORATION·Registered Aug 05, 2022 – Aug 05, 2027ActiveRegistration details
- Analysis ID
- d4d0a851bb52dbbe277362c8559fc7ac
Company information
- Manufacturer
- APEX BIOTECHNOLOGY CORPORATION
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- APEX BIOTECHNOLOGY CORPORATION
Product details
- Intended Use
- Limited to the classification and grading management of medical equipment, quality control materials (analytical and non-analytical) (A.1660) the first level identification range.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1660 Quality control materials (analytical and non-analytical)
- Import Information
- QMS/QSD;; 國產
Dates and status
- Registration Date
- Aug 05, 2022
- Expiry Date
- Aug 05, 2027
About this record
Access comprehensive regulatory information for Wudingliu glucose quality control solution (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number d4d0a851bb52dbbe277362c8559fc7ac and manufactured by APEX BIOTECHNOLOGY CORPORATION. The authorized representative in Taiwan is APEX BIOTECHNOLOGY CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices